MedPath

Fractional Photothermolysis for the Treatment of Burn Scars

Phase 1
Conditions
Scar
Registration Number
NCT01005992
Lead Sponsor
Clinica las Condes, Chile
Brief Summary

The aim of our study is to determine the effect of fractional photothermolysis laser in the treatment of burn scars.

Detailed Description

One of the main problems in the management of burned patients is the treatment of post-burn scarring. Frequently this scars cover large areas, tend to retract, present pigmentary changes and are disfiguring, producing significant life quality impairment.

Unfortunately, there are very few therapeutic options for treating these scars, which can be secondary to reconstructive surgery or after spontaneous healing. In the last decades most reports in scar treatment have included, pressure garments, chemical peeling, dermabrasion, ablative and non-ablative laser therapy and surgery with varying degrees of success. There is only one report treating burn scars with fractional laser, with good results.

The aim of our study is to determine the effect of of a second-generation erbium-doped 1,550-nm fractional photothermolysis laser (Fraxel SR laser, Reliant Technologies Inc.) in the treatment of burn scars.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Burn scars should be located on the anterior thorax or abdomen with at least 4 months of evolution.
  • The scar should be slightly elevated, with erythema and with no signs of keloid formation.
  • Maximum scar dimension: 0.2 - 1% body surface area.
  • Acceptance of informed consent for laser treatment.
Exclusion Criteria
  • Previous non-surgical treatment (i.e. dermabrasion, laser, peelings, bleaching agent. etc).
  • Previous surgical treatment (i.e. graft)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Evidence of improvement in color and texture of burn scars, using digital colorimeter and digital photography.5 months
Adverse effects: pain, erythema, edema, hypopigmentation, hyperpigmentation, hypertrophic scar and keloid formation5 months
Secondary Outcome Measures
NameTimeMethod
Change in surface area and perimeter of burn scar5 months
Tissue pliability, elevation and flexibility with a digital piedemeter5 months
Change in collagen fiber organization and blood vessel density with a reflectance laser confocal microscope.5 months

Trial Locations

Locations (1)

Clinica Las Condes

🇨🇱

Santiago, RM, Chile

Clinica Las Condes
🇨🇱Santiago, RM, Chile
Rodrigo J Schwartz, MD
Principal Investigator
Fresia Solias
Contact
investigacion@coaniquem.cl
Fresia Solis
Sub Investigator
Gonzalo Eguiguren, MD
Sub Investigator
Jorge Rojas, MD
Sub Investigator
pedro lobos, MD
Sub Investigator
Patricia Apt, MD
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.